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Abstract. 
 
The activity of integrins on leukocytes is kept 
under tight control to avoid inappropriate adhesion 
while these cells are circulating in blood or migrating 
through tissues. Using lymphocyte function-associated 
antigen-1 (LFA-1) on T cells as a model, we have inves-
tigated adhesion to ligand intercellular adhesion mole-
cule-1 induced by the Ca
 
2
 
1
 
 mobilizers, ionomycin, 2,5-
di-t-butylhydroquinone, and thapsigargin, and the well 
studied stimulators such as phorbol ester and cross-
linking of the antigen-specific T cell receptor (TCR)–
CD3 complex. We report here that after exposure of T 
cells to these agonists, integrin is released from cyto-
skeletal control by the Ca
 
2
 
1
 
-induced activation of a 
calpain-like enzyme, and adhesive contact between 
cells is strengthened by means of the clustering of mo-
bilized LFA-1 on the membrane. We propose that 
methods of leukocyte stimulation that cause Ca
 
2
 
1
 
 
fluxes induce LFA-1 adhesion by regulation of calpain 
activity. These findings suggest a mechanism whereby 
engagement of the TCR could promote adhesion 
strengthening at an early stage of interaction with an 
antigen-presenting cell.
 
L
 
ymphocytes 
 
have a dual function that requires they
must circulate in nonadherent form through blood
and lymph, but become adherent to allow transmi-
gration across the vasculature or after contact with an anti-
gen-presenting cell in a lymph node. Regulation of adhe-
sion is achieved by controlling the activity of receptors
such as the integrins on the cell surface. The major integrin
on T cells is termed lymphocyte function-associated anti-
gen-1 (LFA-1).
 
1
 
 This integrin is a heterodimeric trans-
membrane receptor composed of a unique 
 
a
 
 subunit (
 
a
 
L;
CD11a) and a 
 
b
 
2 subunit (CD18) that is common to a sub-
set of leukocyte integrins. Leukocyte integrins such as
LFA-1 are not constitutively adhesive, but become firmly
able to engage their ligands after stimuli received through
other cell membrane receptors such as the antigen-specific
T cell receptor (TCR) (Brown and Hogg, 1996; Shaw and
Dustin, 1997). How the signal transduction pathways in-
volved in this “inside out” signaling alter the adhesive state
of integrin on the membrane, and whether these alter-
ations are similar for all integrins, needs clarification. Inte-
grin-mediated adhesion can occur through avidity changes
(Jakubowski et al., 1995; Stewart et al., 1996), but there is
also evidence that some naturally occurring agonists cause
an increase in the intrinsic affinity of the integrin (Faull
and Ginsberg, 1995). Treatment with divalent cations Mn
 
2
 
1
 
or Mg
 
2
 
1
 
/EGTA is an alternative method for inducing ac-
tive integrin with increased affinity (Stewart and Hogg,
1996). This form of integrin activation is considered to al-
ter the ectodomain directly, bypassing the requirement for
intracellular signaling events (Kassner et al., 1994; Stewart
et al., 1996).
The cytoplasmic domains of integrins are essential for
control of their function. Mutation or deletion of specific
cytoplasmic sequences causes integrins to be constitutively
active and has also revealed links with the cytoskeleton
(Hughes et al., 1995; Peter and O’Toole, 1995; Lu and
Springer, 1997). Interaction with the cytoskeleton is regu-
lated during the course of adhesion and may be involved
at more than one stage of the adhesion process. For exam-
ple, LFA-1 is reported to associate with the cytoskeleton
after TCR–CD3 cross-linking (Pardi et al., 1992), but low
doses of the cytoskeletal disrupting agent cytochalasin fa-
cilitates adhesion by Mac-1 and LFA-1 (Elemer and Edg-
ington, 1994; Kucik et al., 1996; Lub et al., 1997).
Increases in cytoplasmic Ca
 
2
 
1
 
 ([Ca
 
2
 
1
 
]
 
i
 
) accompany trigger-
ing through the TCR and are also an important component
of other adhesion-inducing mechanisms. [Ca
 
2
 
1
 
]
 
i
 
 activates
enzymes and mediators such as protein kinase C (PKC),
calcineurin, calmodulin, calreticulin, myosin light chain
kinase (MLCK), and calpain, many of which have been
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implicated in integrin function. For example, Ca
 
2
 
1
 
-acti-
vated calcineurin functions in the recycling of integrin
 
a
 
v
 
b
 
3 on the moving neutrophil (Hendey et al., 1992; Law-
son and Maxfield, 1995). Phorbol ester-induced T cell ad-
hesion to intercellular adhesion molecule-1 (ICAM-1) is
Ca
 
2
 
1
 
-dependent (Rothlein and Springer, 1986; Stewart et
al., 1996), and Ca
 
2
 
1
 
 ionophores such as ionomycin can
cause integrin-mediated adhesion (Altieri et al., 1988;
Hartfield et al., 1993; van Kooyk et al., 1993). Ca
 
2
 
1
 
 fluxes
also activate actin-binding proteins causing actin dissocia-
tion and cytoskeletal rearrangements (Stossel, 1989).
In this study, we have used three Ca
 
2
 
1
 
 mobilizing
agents, ionomycin, thapsigargin, and 2,5-di-t-butylhydro-
quinone (dBHQ) as tools to gain further understanding of
the role of Ca
 
2
 
1
 
 in the activation of adhesion by the inte-
grin LFA-1. By inducing Ca
 
2
 
1
 
 fluxing, the objective was to
short circuit the early phases of signaling to dissect the
events leading more immediately to adhesion. We show that
these three reagents, as well as cross-linking the TCR–
CD3 complex (XL-TCR–CD3) and phorbol ester treatment,
induce LFA-1–mediated adhesion through a mechanism in-
volving activation of calpain. The presented results suggest
that Ca
 
2
 
1
 
-mediated activation of calpain releases LFA-1
from cytoskeletal control allowing integrin clustering.
 
Materials and Methods
 
Reagents
 
Ionomycin, thapsigargin, phorbol 12,13 dibutyrate (PdBu), and the mem-
brane soluble calpain inhibitor calpeptin were obtained from Calbiochem/
Novabiochem Corp. (La Jolla, CA); dBHQ, and the calpain inhibitor,
CBZ-LVG, were purchased from Sigma Chemical Co. (Dorset, UK). Jas-
plakinolide was obtained from Molecular Probes, Inc. (Eugene, OR).
SK&F 96365 was purchased from BiomoL Feinchemikalien GmbH
(Hamburg, Germany). With the exception of SK&F 96365, which was di-
rectly soluble in H
 
2
 
O, stock concentrations of inhibitors were prepared in
DMSO and in every relevant experiment an equivolume of DMSO was
added in the control sample. The above reagents had no effect on the via-
bility of the T cells at the levels used in the reported experiments.
 
Flow Cytometry, mAbs, and Assessment of Soluble 
ICAM-1Fc Binding
 
A dimeric form of an ICAM-1Fc chimaeric protein consisting of the five
extracellular domains of ICAM-1 fused to the Fc fragment of human IgG1
was prepared as previously described (Berendt et al., 1992). Flow cytome-
try and measurement of the binding of soluble recombinant ICAM-1Fc to
T cells was carried out as previously described (Stewart et al., 1996).
mAbs used in this study were the LFA-1 
 
a
 
 subunit (CD11a) mAbs 38
(Dransfield and Hogg, 1989), F110.22 (Schmidt, 1989), and G25.2 (Becton
and Dickinson Co., Mountain View, CA). The anti-CD3 mAbs G19.4 and
UCHT1 were obtained from Bristol Myers Squibb (Seattle, WA) and
P. Beverley (University College, London), respectively. The secondary
FITC-conjugated antibodies goat anti–mouse IgG Fc and goat anti–human
IgG Fc were obtained from Jackson ImmunoResearch Laboratories, Inc.
(West Grove, CA).
 
T Cell Adhesion to ICAM-1Fc
 
T lymphoblastoid cells were expanded from unstimulated peripheral
blood mononuclear cells by culture for 1–2 wk in RPMI-1640 medium
containing recombinant IL-2 (20 ng/ml; Cetus Corp., Berkeley, CA) with
details as previously described (Dransfield et al., 1992). Cells were used
between days 10 and 14. The method for quantifying T cell adhesion to
ICAM-1Fc protein has been previously described (Stewart et al., 1996),
with the exception that the assay buffer used was RPMI 1640 unless con-
trolled cation conditions were being analyzed. For these experiments T
cells were treated with 5 mM Mg
 
2
 
1
 
/1 mM EGTA in Hepes/NaCl buffer.
 
The ICAM-1Fc protein was coated at 0.24 
 
m
 
g/well onto 96-well Immulon
1 plates (Dynatech, Chantilly, VA).
 
Confocal Microscopy
 
For immunofluorescence analysis by confocal microscopy, 13-mm-round
glass coverslips were precoated with a 0.01% solution of poly-L-lysine
(Sigma Chemical Co.) for 10 min at room temperature, washed twice in
RPMI 1640, and then left to air dry. T cells were washed three times in
RPMI 1640 buffer before addition onto coverslips (5 
 
3
 
 10
 
5
 
 cells/cover-
slip), in the presence of stimulants and CD11a mAbs at 10 
 
m
 
g/ml. Cover-
slips were spun at 40 
 
g
 
, and then incubated for 30 min at 37
 
8
 
C. Unbound
cells were removed by gentle washing in warm RPMI 1640 buffer. To pre-
vent antibody-induced clusters, cells were fixed with 1% formaldehyde in
PBS-A for 10 min at room temperature before a second incubation with
10 
 
m
 
g/ml FITC-conjugated goat anti–mouse IgG Fc (Jackson ImmunoRe-
search Laboratories) for 25 min at 4
 
8
 
C. Cells stimulated via CD3 trigger-
ing were incubated with CD3 mAbs UCHT1 or G19.4 for 30 min at 37
 
8
 
C
and fixed as above.
Cells were mounted for confocal microscopy which was carried out us-
ing a MRC-600 Confocal Laser Scanning System (Bio-Rad Laboratories
Ltd, Hertfordshire, UK). The regions of the confocal microscopy images
with the highest fluorescence intensity (i.e., with the pixel color intensity in
the 150–255 range) were highlighted in red using the segmentation utility of
the IP Lab Spectrum Version 3.1 software (Signal Analytics Co., Vienna, VA).
This software was also used to quantify the levels of fluorescence on
the images. Background fluorescence was estimated by measuring the sig-
nal strength in areas visibly devoid of specific staining but in close proxim-
ity to cells. The average of these values was then subtracted from the orig-
inal image to give a corrected image. The areas of interest (e.g., free
membrane or membrane at cell–cell contact points) on the corrected im-
ages were selected and the average signal strength calculated automati-
cally by the computer software. A statistical assessment of the differences
between the treatment groups and the untreated resting T cells was per-
formed using the one-way ANOVA test.
 
Results
 
Agents That Mobilize Intracellular Ca
 
2
 
1
 
 Induce
LFA-1 Adhesion
 
To gain insight into the role of Ca
 
2
 
1
 
 in LFA-1 adhesion, we
have analyzed the effect on leukocyte adhesion to ICAM-1
of the Ca
 
2
 
1
 
 ionophore ionomycin and two other Ca
 
2
 
1
 
 mo-
bilizers, thapsigargin, and dBHQ. The latter two com-
pounds act by inhibiting the ATPase pumps on Ca
 
2
 
1
 
 stor-
age organelles, which maintain homeostasis by pumping
Ca
 
2
 
1
 
 from the cytosol into these organelles and the endo-
plasmic reticulum (Thomas and Hanley, 1994). Inhibition
of pump action causes emptying of intracellular Ca
 
2
 
1
 
 stores
and a resultant Ca
 
2
 
1
 
 influx across the plasma membrane
via capacitative entry (Thastrup et al., 1990). The three
agents showed a dose-dependent stimulation of T cell
LFA-1–mediated adhesion to immobilized ICAM-1 (Fig.
1). The peak adhesion with ionomycin, thapsigargin, and
dBHQ occurred at 0.7, 
 
z
 
5, and 
 
z
 
50 
 
m
 
M, respectively. The
higher optimal concentration of dBHQ may be due to its
comparatively poor ability to penetrate the plasma mem-
brane (Thomas and Hanley, 1994). The reason for the
phase of decline in the bell-shaped response curves was
not due to loss of cell viability, but was not further pur-
sued. Therefore, mobilization of [Ca
 
2
 
1
 
]
 
i
 
 by three distinct
agents can cause LFA-1–mediated T cell adhesion, high-
lighting a role for [Ca
 
2
 
1
 
]
 
i
 
 in the LFA-1 activation pathway.
 
LFA-1–mediated Adhesion after Ca
 
2
 
1
 
 Mobilization 
Requires Extracellular Ca
 
2
 
1
 
The tested pharmacological agents raise [Ca
 
2
 
1
 
]
 
i
 
 levels not 
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only by inducing release from intracellular stores, but also
by capacitative fluxing in through the plasma membrane
(Putney and Bird, 1993; Breittmayer et al., 1994; Wenzel-
Seifert et al., 1996). To define the source of Ca
 
2
 
1
 
 that
facilitates T cell adhesion, we made use of the imidazole
compound SK&F 96365, which blocks Ca
 
2
 
1
 
 channels on leu-
kocytes that open as a result of depletion of Ca
 
2
 
1
 
 stores
(Wenzel-Seifert et al., 1996). Adhesion stimulated by ion-
omycin, thapsigargin, through the TCR–CD3 complex,
and by PdBu was inhibited by SK&F 96365 (Fig. 2). As ex-
pected, T cell adhesion to ICAM-1 induced by Mg
 
2
 
1
 
/EGTA
was not altered by the Ca
 
2
 
1
 
 channel blocker (Stewart et
al., 1996). Further evidence that extracellular Ca
 
2
 
1
 
 has an
intracellular function came from the use of the intracellu-
lar Ca
 
2
 
1
 
 chelator BAPTA–AM, which at 20–30 
 
m
 
M re-
duced LFA-1 adhesion by 50–80% for all inducers in this
study with the exception of Mg
 
2
 
1
 
/EGTA (data not shown).
Therefore, adhesion stimulated in several ways by “inside
out” signaling is dependent upon an extracellular source
of Ca
 
2
 
1
 
.
 
Measurements of Soluble ICAM-1 Binding
 
To investigate the mechanism of Ca
 
2
 
1
 
 action, the charac-
teristics of LFA-1–mediated adhesion caused by the Ca
 
2
 
1
 
mobilizers was examined. One question of interest was
whether the Ca
 
2
 
1
 
-mediated signaling increased the ability
of LFA-1 to bind soluble ICAM-1 (sICAM-1). In a previ-
ous study, sICAM-1 binding distinguished high affinity
Mg
 
2
 
1
 
-stimulated LFA-1 from low affinity LFA-1 on phor-
bol ester-stimulated and XL-TCR–CD3 T cells (Stewart et
al., 1996). None of the Ca
 
2
 
1
 
 mobilizers showed any induc-
tion of sICAM-1 binding even at sICAM-1 levels of 1 mg/ml
(4.5 
 
m
 
M), in contrast to the enhanced ability of Mg
 
2
 
1
 
-stim-
ulated T cells to bind sICAM-1, which served as a positive
control (Fig. 3). It can be concluded that the Ca
 
2
 
1
 
 mobiliz-
ers resemble the phorbol ester or TCR–CD3 model of ad-
hesion by failing to promote an increase in the ability of
LFA-1 to bind to soluble ICAM-1.
 
Distribution of LFA-1 on T Cells after Exposure to 
Ca
 
2
 
1
 
-mobilizing Agents
 
As the Ca
 
2
 
1
 
 mobilizers did not cause a detectable increase
in the affinity of LFA-1, we used confocal microscopy to
investigate whether the membrane distribution of LFA-1
was altered in a manner facilitating adhesion. To analyze
LFA-1 distribution, we highlighted the confocal micros-
copy images such that the membrane regions with the
highest LFA-1 fluorescence (i.e., in the pixel intensity
range 150–250, where 250 is the highest possible value) are
depicted in red and all others in white (Fig. 4). Unstimu-
lated cells (Fig. 4 
 
a
 
) and Mg
 
2
 
1
 
/EGTA–stimulated cells
(Fig. 4 
 
b
 
) have very little high intensity LFA-1 fluores-
cence (
 
red
 
) in comparison to that of thapsigargin-stimu-
lated cells (Fig. 4 
 
c
 
). These observations were confirmed
by quantifying (see Materials and Methods) the levels of
fluorescence for each sample on regions of the membrane
where there was no contact between cells (Table I, 
 
Free
membrane
 
). Statistical analysis (one way ANOVA) of
these measurements confirmed that the level of fluores-
cence on the thapsigargin-stimulated cells, but not on the
Mg
 
2
 
1
 
/EGTA–stimulated T cells, was significantly increased
compared to the level on the resting T cells (Table I, 
 
Sig-
nificance levels
 
). This increase in the intensity of LFA-1
fluorescence upon thapsigargin stimulation was detected
with three distinct CD11a mAbs, 38, F110.22, and G25.2
(data not shown), and therefore does not represent the ex-
posure of a particular epitope. These results suggested that
thapsigargin might stimulate an increase in the cell surface
expression of LFA-1. When measured by flow cytometry,
Figure 1. Ca21 mobilizers induce adhesion of T cell LFA-1 to
ICAM-1Fc. T cells were treated with ionomycin, thapsigargin,
and dBHQ at the indicated concentrations and incubated on
ICAM-1Fc–coated 96-well plates for 30 min at 378C. The propor-
tion of adhering cells was calculated as a percentage of total cells
added per well. For all stimulants, adhesion was reduced to back-
ground levels by means of anti–LFA-1 mAb used at 10 mg/ml. An
experiment representative of five similar experiments is pre-
sented.
Figure 2. Thapsigargin and ionomycin-induced adhesion is de-
pendent on extracellular Ca21. T cells were preincubated with
100 mM SK&F 96365 in RPMI for 30 min at 378C, and then incu-
bated with thapsigargin (5 mM) and ionomycin (0.7 mM) on
ICAM-1Fc–coated 96-well plates for a further 30 min at 378C.
The proportion of adhering cells was calculated as a percentage
of total cells added per well. For all stimulants, adhesion was re-
duced to background levels by anti–LFA-1 mAb used at 10 mg/
ml. An experiment representative of three is presented.The Journal of Cell Biology, Volume 140, 1998 702
however, results revealed that the level of LFA-1 expres-
sion after thapsigargin stimulation did not differ from
LFA-1 expression on the resting or Mg21/EGTA–treated
cells (Table I, Flow cytometry). This suggested that the in-
crease in signal strength observed by confocal microscopy
upon thapsigargin stimulation reflects increased clustering
that creates a higher LFA-1 fluorescence intensity. Similar
results were obtained with the other Ca21-mobilizing agents,
with PdBu, and by XL-TCR–CD3 (data not shown).
It was observed that some of the brightest LFA-1 fluo-
rescence was found where cells were in contact with each
other, and we therefore quantified the level of fluores-
cence in these regions (Table I, Contact zone) to deter-
mine whether this high fluorescence reflected a redistribu-
tion of LFA-1 to cell–cell contacts or was merely the
additive value of the two cell membrane measurements.
As the ratio of the average fluorescence intensity at cell
contact areas to that of free membrane was z2 (Table I,
Contact/Free), we concluded that there is no large scale re-
distribution of LFA-1 to points of cell contact upon thapsi-
gargin treatment. In summary, the confocal results re-
vealed that upon thapsigargin stimulation LFA-1 becomes
clustered but does not change its distribution to regions of
the cell membrane in contact with other cells. Similar re-
sults were obtained with the other Ca21-mobilizing agents
as well as PdBu (data not shown), and by cross-linking the
TCR/CD3 (see Fig. 7) suggesting that local LFA-1 cluster-
ing may be a general feature of several T cell adhesion-
activating protocols.
Effect of Jasplakinolide on T Cell Adhesion to ICAM-1 
and on LFA-1 Distribution
The implication of the above confocal experiments was
that the Ca21 mobilizers promoted LFA-1 clustering. This
clustering might occur as a result of breakdown of cytoskel-
etal tethering (Elemer and Edgington, 1994; Kucik et al.,
1996; Lub et al., 1997) or, conversely, might follow from
the formation of new cytoskeletal connections (Pardi et al.,
1992). To address these alternative possibilities, we inves-
tigated the effects on LFA-1 adhesion and membrane dis-
tribution of jasplakinolide, a compound that stabilizes pre-
existing actin filaments, promotes actin polymerization, and
prevents actin depolymerization (Bubb et al., 1994). Jasplak-
inolide caused dose-dependent inhibition of LFA-1–mediated
adhesion to ICAM-1 with complete inhibition between 1 to
2 mM (data not shown). Therefore, the general inhibitory
effects of jasplakinolide on agonists that indirectly stimu-
late LFA-1–mediated adhesion is consistent with a require-
ment for disassembly of the actin cytoskeleton.
We next used confocal microscopy to ask whether jas-
plakinolide affected the distribution of LFA-1 after pre-
treatment of thapsigargin-stimulated T cells. As seen in
Fig. 5, jasplakinolide diminished the fluorescence levels of
LFA-1 detected by confocal microscopy (i.e., there is less
fluorescence highlighted [red] in Fig. 5 b than in a). Identi-
cal levels of LFA-1 expression were detected by flow cy-
tometry before and after jasplakinolide treatment (data
not shown), indicating that the inhibitor interfered with
LFA-1 clustering rather than causing receptor loss. Similar
results were obtained after T cell stimulation with phorbol
ester and through CD3–TCR (data not shown). Therefore,
clustering of LFA-1 on the membrane is dependent on the
disassembly of the actin fibers, suggesting that adhesion
through LFA-1 clustering is promoted by active release
from restraints imposed by the cytoskeleton.
Analysis of the Intracellular Molecules Controlling 
LFA-1–mediated Adhesion: Involvement of Calpain in 
Ca21-induced Effects
In an attempt to understand the molecular mechanism by
which Ca21 induces LFA-1 clustering, we investigated the
effect of inhibitors and mAbs specific for several major
Ca21-using enzymes that have a link with adhesion. After
stimulation with ionomycin or thapsigargin, we failed to find
a role for PKC, calcineurin, or calmodulin using the spe-
cific inhibitors Ro 31-8220 (1–5 mM), FK506 (0–7 ng/ml),
and trifluoperazine (0.5–10 mM), respectively. Similarly,
immunoprecipitation and blotting with specific antibodies
failed to show an association of the 208-kD MLCK (Gal-
lagher et al., 1995) or calreticulin (Coppolino et al., 1995)
with stimulated LFA-1 (data not shown).
Another enzyme activated by Ca21 is calpain, a multi-
functional protease that is located in the cytosol (Sorima-
chi et al., 1994). We monitored LFA-1 adhesion stimulated
by thapsigargin, PdBu, XL-TCR–CD3, and Mg21/EGTA
after preincubation with the membrane permeable calpain
inhibitor, calpeptin (Tsujinaka et al., 1988; Kwak et al.,
1993). This agent caused maximal inhibition of T cell ad-
hesion at 100 mg/ml (280 mM) after stimulation by thapsi-
gargin, PdBu, and XL-TCR–CD3, but had no effect on
Mg21-induced adhesion (Fig. 6). A further calpain inhibi-
tor, CBZ-LVG, also blocked adhesion at similar concen-
trations (data not shown). There was no alteration in cell
viability at concentrations at which these inhibitors were
maximally active. We next found that the levels of clus-
Figure 3. Thapsigargin, ionomcyin, and dBHQ do not induce
binding of soluble ICAM-1 to LFA-1. Soluble ICAM-1Fc at 1
mg/ml (or 4.5 mM) was incubated with thapsigargin (5 mM), ion-
omcyin (0.7 mM), dBHQ (50 mM), PdBu (50 nM), and Mg21/
EGTA (5 mM/1 mM)–stimulated cells for 30 min at 378C (Stew-
art et al., 1996). Bound sICAM-1 was detected with FITC-conju-
gated goat anti–human (Fc specific) Ab and analyzed by flow cy-
tometry. Results are expressed as median fluorescence intensity.
An experiment representative of three is presented.Stewart et al. A Model for LFA-1–mediated Adhesion 703
tered LFA-1 detected after treatment with thapsigargin
(Fig. 7 a), XL-CD3 (Fig. 7 b), and PdBu (data not shown)
were diminished by calpeptin treatment (i.e., there is less
fluorescence highlighted [red] in Fig. 7 c than in a and in
Fig. 7 d than in b) to levels similar to those on resting T
cells (Table I, Free membrane).
The calpain inhibitors used in this study are not entirely
specific for calpain but also inhibit lysosomal cathepsins
and proteasome activity. To rule out the involvement of
the proteasome, we investigated the effect of the highly
specific proteasome inhibitor lactacystin on T cell adhe-
sion to ICAM-1. Although antigen presentation was inhib-
ited by 20 mM lactacystin (Correa, I., and J. Trowsdale,
personal communication) T cell adhesion was unaffected
by concentrations as high as 200 mM (data not shown).
Furthermore, T cells lack lysosomal cathepsins that are
also susceptible to the calpain inhibitors. In summary,
these results indicate that a calpain-like enzyme is pivotal
in causing the clustering of LFA-1 and by this means adhe-
sion to ICAM-1 is facilitated.
Table I. Detection of T Cell LFA-1 by Either Confocal Microscopy or Flow Cytometry after Activating Treatments
Confocal microscopy Flow cytometry
Significance levels 
(compared to resting T cells)
Contact zone (fluorescence) Free membrane (fluorescence) F1,103 P Contact/free Fluorescence
fluorescence units 6 SEM fluorescence units 6 SEM MFI
Resting T cells 58.2 6 6.1 n 5 23 — — 112.4 6 10.4 1.93 858.6
Mg21/EGTA 60.5 6 4.8 n 5 33 0.09 .0.1 131.8 6 6.5 2.18 897.9
Thapsigargin 102.3 6 4.8 n 5 33 31.90 ,0.0001 185.8 6 5.7 1.82 827.4
Thapsigargin and 57.8 6 7.6 n 5 18 0.00 .0.1 109.6 6 14.1 1.90 909.6
calpeptin
On T cells visualized by confocal microscopy, the level of LFA-1 was quantified (see Materials and Methods) on the membrane where there was no cell contact (Free membrane)
or at T cell contact points (Contact zone). When the fluorescence units (6 SEM) were compared between treatment groups, only the thapsigargin-treated samples differed signifi-
cantly from the resting T cell sample (Significance levels). To ask whether LFA-1 redistributes to cell–cell contact zones, a ratio of contact zone fluorescence and free membrane
fluorescence was calculated (Contact/free). In no sample was the ratio significantly different from 2.0, indicating that the level of LFA-1 at cell–cell contact zones was the sum of
the fluorescence of the two associated membranes and therefore LFA-1 did not preferentially migrate to regions of the membrane where cells are in contact. In the same experi-
ments, the samples were measured by flow cytometry and the level of LFA-1 (MFI) demonstrated not to differ significantly between samples (Flow cytometry).
Figure 5. Thapsigargin stimulates LFA-1 clustering through a cy-
toskeletal release mechanism. T cells adhered onto poly-L-lysine
were either (a) treated with 5 mM thapsigargin for 30 min at 378C,
or (b) preincubated with 1 mM jasplakinolide for 30 min at 378C,
before treatment as in a. LFA-1 was detected with FITC-conju-
gated LFA-1 specific mAb and analyzed by confocal microscopy
as in Fig. 4. Bar, 10 mm.
Figure 4. Thapsigargin stimulates LFA-1 clustering. T cells ad-
hered onto poly-L-lysine were (a) unstimulated; (b) treated with
5 mM Mg21/1 mM EGTA; or (c) treated with 5 mM thapsigargin
for 30 min at 378C. LFA-1 was detected with FITC-conjugated
LFA-1–specific mAb and analyzed by confocal microscopy. Red
color indicates fluorescence intensity exceeding a preset pixel
value (see Materials and Methods). This setting remained con-
stant between samples. Bar, 10 mm.The Journal of Cell Biology, Volume 140, 1998 704
Discussion
In this study, we have examined a role for Ca21 in the in-
duction of integrin-mediated adhesion, using the leukocyte
integrin LFA-1 on T cells as the model. Three agents that
cause Ca21 mobilization trigger LFA-1–mediated adhesion
to ICAM-1 to the same extent as other inside out inducers
of adhesion such as XL-TCR–CD3 and phorbol ester. Fur-
thermore, all three forms of stimulation cause LFA-1 clus-
tering on T cells. The following points can be made about
the Ca21-dependent mechanism by which adhesion is
brought about: (a) LFA-1 clusters in the cell membrane
thereby strengthen adhesion by increasing the integrin
avidity; (b) the adhesion is dependent upon Ca21 influx;
(c) the overall affinity of LFA-1 for ligand does not alter
as no increase in the ability to bind soluble ICAM-1 can be
detected; (d) both adhesion and LFA-1 redistribution are
prevented by inhibiting cytoskeletal disassembly, implying
a role for actin reorganization; (e) calpain has a central
role in the clustering of LFA-1; (f) the above features are
not shared by Mg21/EGTA–treated LFA-1, which binds
ICAM-1 with high affinity and mediates adhesion without
dependence on the intracellular events described here.
Stimulation of T cells by the Ca21 mobilizers, through
the TCR–CD3 complex and by phorbol ester, results in an
increase in integrin avidity by clustering of LFA-1 in the
membrane. These results are in agreement with previous
reports of integrin clustering after phorbol ester stimulation
(Burn et al., 1988; Kupfer and Singer, 1989). Both phorbol
esters and the other Ca21-dependent adhesion inducers
used in this study cause LFA-1 clustering over the entire
cell membrane. In a more physiological setting, when the
TCR is triggered upon T cell–APC contact Ca21 fluxes oc-
cur locally (Zweifach and Lewis, 1993; Hall et al., 1993;
Donnadieu et al., 1994; Negulescu et al., 1996). The subse-
quent effect on LFA-1 would be confined to the immedi-
ate points of cell contact. Support for this prediction comes
from the observation that LFA-1 segregates away from the
“TCR clusters” after TCR signaling, and therefore is no
longer uniformly distributed (Dustin et al., 1996). Whether
clustering involves direct lateral association between inte-
grin subunits or is driven by ligand (Singer, 1992) requires
further investigation. The expression of the epitopes of
both nonfunction blocking (G25.2) and function blocking
(38, F110.22) anti–LFA-1 a-subunit mAb epitopes is com-
parable when detected by confocal microscopy, implying
that the clustering in this study is probably not driven by
ligand (data not shown). The work of van Kooyk et al.
(1994) suggests that Ca21 may also have an extracellular
role in integrin multimerization. Finally, a recent analysis
of a4 integrin made use of the confocal microscope to in-
vestigate integrin clustering in the absence of an alteration
in a4 integrin cell membrane expression (Yauch et al., 1997)
in a similar manner to the approach described in our study.
Calpain is implicated in the clustering and adhesive activ-
ity of LFA-1 by the ability of selective inhibitors to diminish
these processes. Calpains are Ca21-dependent neutral cys-
teine proteases that are activated by local Ca21 fluxes and
are widely expressed in mammalian cells (Suzuki et al., 1987;
Saido et al., 1994; Sorimachi et al., 1994). Calpain is highly
expressed in T cells and is increased at both mRNA and
protein levels by phorbol ester, calcium ionophore, and
anti-CD3 treatment, all agents that can induce LFA-1 ad-
hesion (Deshpande et al., 1995). In platelets Ca21 iono-
phore will directly activate calpain, but when platelets are
stimulated by a physiological agonist, such as thrombin,
calpain activation is then dependent upon interaction of
integrin aIIbb3 with ligand (Fox et al., 1993). However,
for T cells, the evidence suggests that the Ca21 flux is not
dependent on ligand binding by LFA-1, but, as we argue
here, is directly responsible for LFA-1 clustering, with
ligand binding a secondary event. Firstly, anti-CD3 stimu-
lation of T cells causes activation of calpain proteolytic ac-
tivity (Selliah et al., 1996). Secondly, the Ca21 flux in T cells
Figure 6. Calpain inhibitors block LFA-1–mediated adhesion in-
duced by agonists acting intracellularly. Cells were preincubated
with or without 280 mM (100 mg/ml) calpeptin for 30 min at 378C
before analysis in a T cell adhesion assay where stimulants were
50 nM PdBu, 5 mM thapsigargin, 10 mg/ml anti-CD3 mAb G19.4,
5 mM Mg21/1 mM EGTA.
Figure 7. LFA-1 clustering induced by thapsigargin and anti-
TCR–CD3 triggering is inhibited by calpeptin. Clustering of
LFA-1 induced by 5 mM thapsigargin (a) and 10 mg/ml anti-CD3
mAb (b) was prevented by preincubation with 100 mg/ml calpep-
tin, (c and d, respectively), for 30 min at 378C. Bar, 10 mm.Stewart et al. A Model for LFA-1–mediated Adhesion 705
stimulated in this manner is not affected by function
blocking CD11a and CD18 mAbs (Monard, 1991). Finally,
there has been no indication that LFA-1 is physically asso-
ciated with Ca21 channel activity as has been suggested for
aIIbb3 (Rybak et al., 1988; Fujimoto et al., 1991). There-
fore, the evidence suggests that calpain activity is regu-
lated differently in these two cell types, but this does not
preclude further action of calpain after the ICAM-1 bind-
ing phase of T cells.
There are a number of possibilities to explain how cal-
pain might be acting. Calpain may be activated to cleave a
key protein, physically releasing LFA-1 from its cytoskele-
tal restraint and allowing movement in the membrane as
observed by single particle tracking (Kucik et al., 1996)
and resonance energy transfer studies (Poo et al., 1994).
Proteins that have been identified as calpain targets in-
clude talin (Inomata et al., 1996), filamin (Collier and Wang,
1982), and a-actinin (Selliah et al., 1996). In resting
PBMC, both filamin and a-actinin are associated with
CD18 (Pavalko and LaRoche, 1993; Sharma et al., 1995),
and in T cells calpain cleaves a-actinin after TCR–CD3 trig-
gering (Selliah et al., 1996) with kinetics similar to that of
LFA-1–mediated adhesion (Dransfield et al., 1992; Dustin
and Springer, 1989). Another possibility is that calpain
cleaves a signaling protein. Potential candidates include
focal adhesion kinase (Cooray et al., 1996) and phosphoty-
rosine phosphatase kinase 1B (Frangioni et al., 1993). It
will be of interest to test the sensitivity to calpain of LFA-
1–binding proteins such as cytohesin-1 (Kolanus et al.,
1996). There is evidence that calpain can cleave the b3
subunit (Du et al., 1995). Whether the b2 subunit can also
be cleaved by calpain remains to be investigated, and it is
uncertain whether a b2 integrin cleaved at the sites homol-
ogous to the b3 calpain sensitive sites would be able to at-
tach to the cytoskeleton or to bind ligand.
The cytoskeleton is intimately involved in the adhesive
process. Use of jasplakinolide, an agent that inhibits actin
disassembly (Bubb et al., 1994) prevents LFA-1 clustering
and T cell adhesion. Alternatively, low levels of cytochala-
sin D promote integrin-mediated adhesion (Elemer and
Edgington, 1994; Kucik et al., 1996; Lub et al., 1997; Yauch
et al., 1997) and allow movement of the integrin in the mem-
brane (Kucik et al., 1996). Put together, these findings in-
dicate that in the nonactive state, LFA-1 is tethered to the
cytoskeleton and release from this constraint allows motil-
ity leading to LFA-1 clustering and adhesion to ICAM-1.
LFA-1 has also been reported to associate with cytoskele-
tal elements after activation (Pardi et al., 1992), and it is
possible that clustered integrin, either before or after con-
tact with ligand, might renew interaction with the cytoskel-
eton. The role of calpain in cytoskeletal rearrangements
remains unresolved. Cytoskeletal reorganization may be
necessary for the exposure of the proteolytic target of
calpain or, conversely, calpain activation may lead to alter-
ations in the cytoskeleton itself. Phorbol ester and other
stimulants also cause coincident PKC and calpain translo-
cation to the membrane (Pontremoli et al., 1989; Hong et al.,
1995). In platelets activating agonists are reported to cause
calpain to move from a generalized distribution in cells to
a peripheral location (Fox et al., 1993), and this could be
brought about by cytoskeletal reorganization.
Here we have provided evidence that the protease cal-
pain plays a role in the regulation of LFA-1 adhesion in-
duced by Ca21 flux. This process involves an increase in
ligand-binding avidity of the T cell through clustering of
LFA-1 but no detectable increase in LFA-1 affinity. In many
aspects this route to LFA-1 adhesion differs from that of
Mg21/EGTA treatment, which requires neither Ca21 nor
calpain but activates from the “outside” causing an affinity
increase in LFA-1, indicating direct integrin conforma-
tional change (Stewart et al., 1996). Thus, there are two al-
ternative pathways to LFA-1–mediated adhesion with dif-
ferent mechanisms. Migrating cells need adhesive contacts
that can be rapidly made and easily broken. We suggest
here that such contacts may be regulated through proteol-
ysis and cytoskeletal control. On the other hand, once a
leukocyte has arrived at an inflammatory site, migration is
halted and stable cell–cell contacts form, which may then
allow the bi-directional signaling necessary for other as-
pects of T cell function (Shaw and Dustin, 1997). High af-
finity adhesion would be an efficient means of facilitating
these interactions and therefore it is of interest that the
Mg21 concentration of wound fluids is in favorable bal-
ance with Ca21 and considerably higher than in normal
plasma (Grzesiak and Pierschbacher, 1995). There is also
evidence that this higher affinity LFA-1 may succeed the
primary low affinity interaction of LFA-1 as a result of
conformational change brought about by contact with
ligand (Cabañas and Hogg, 1993).
In summary, our findings show that the Ca21-regulated
activation of calpain causes the clustering of LFA-1, possi-
bly by cleaving a key cytoskeletal component. In vivo this
Ca21-induced clustering would be speculated to be con-
fined to local sites of receptor triggering. Recent studies
have outlined the phases of contact between T cells with
antigen-presenting cells and highlight the importance of
local Ca21 fluxes in converting the motile “scanning” T cell
into an immobile cell, stably engaged with its partner
(Donnadieu et al., 1994; Negulescu et al., 1996). Our ob-
servations lead to the prediction that any receptor trigger
which stimulates a Ca21 flux in T cells would induce LFA-1
adhesion. It will be interesting to discover whether this
mechanism is unique to control of LFA-1 adhesion or part
of the adhesion mechanism for integrins found on other
cells.
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